PartnerRe Asset Management’s Biogen BIIB Stock Holding History

PartnerRe Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,472	Closed	-$383K	–	55
2016 Q1	$383K	Hold	1,472	–	–	0.19%	79
2015 Q4	$451K	Sell	1,472 -2,784	-65%	-$800K	0.23%	67
2015 Q3	$1.24M	Buy	4,256 +7	+0.2%	+$2.31K	0.21%	76
2015 Q2	$1.72M	Sell	4,249 -722	-15%	-$290K	0.32%	62
2015 Q1	$2.1M	Sell	4,971 -58	-1%	-$22.9K	0.35%	55
2014 Q4	$1.71M	Buy	5,029 +706	+16%	+$228K	0.28%	66
2014 Q3	$1.43M	Sell	4,323 -721	-14%	-$238K	0.28%	65
2014 Q2	$1.59M	Sell	5,044 -669	-12%	-$201K	0.28%	67
2014 Q1	$1.75M	Buy	5,713 +27	+0.5%	+$8.57K	0.29%	70
2013 Q4	$1.59M	Sell	5,686 -372	-6%	-$96.2K	0.27%	75
2013 Q3	$1.46M	Sell	6,058 -791	-12%	-$177K	0.25%	79
2013 Q2	$1.47M	Buy	+6,849	New	+$1.46M	0.24%	80

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

PartnerRe Asset Management's BIIB Position: Q2 2016 in Review

PartnerRe Asset Management sold out of Biogen (BIIB) in Q2 2016, closing a stake of 1,472 shares — an estimated $383K sold.

PartnerRe Asset Management first reported a position in BIIB in Q2 2013 and held it in 12 quarters. The position peaked at $2.1M in Q1 2015. 967 funds tracked by Wall St. Rank hold BIIB as of Q2 2016.

PartnerRe Asset Management reported no remaining Biogen position as of Q2 2016 after selling out during the quarter.
PartnerRe Asset Management sold 1,472 Biogen shares in Q2 2016, an estimated $383K.
PartnerRe Asset Management first reported a position in Biogen in Q2 2013 and held it in 12 quarters.
PartnerRe Asset Management's Biogen position peaked at $2.1M in Q1 2015.
967 funds tracked by Wall St. Rank held Biogen as of Q2 2016.

Based on PartnerRe Asset Management's 13F filing for Q2 2016, filed 14 Jul 2016.